carbamates has been researched along with Laryngopharyngeal Reflux in 1 studies
Laryngopharyngeal Reflux: Back flow of gastric contents to the LARYNGOPHARYNX where it comes in contact with tissues of the upper aerodigestive tract. Laryngopharyngeal reflux is an extraesophageal manifestation of GASTROESOPHAGEAL REFLUX.
Excerpt | Relevance | Reference |
---|---|---|
" A mouse model of laryngopharyngeal reflux (mechanical laryngeal injury once weekly for 2 weeks and pH 7 solvent/pepsin instillation 3 days/week for 4 weeks) was provided inhibitor by gavage or aerosol (fosamprenavir or darunavir; 5 days/week for 4 weeks; n = 3)." | 8.31 | Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse Model. ( Arnold, LA; Blumin, JH; Bock, J; Goetz, CJ; Johnston, N; MacKinnon, AC; Miller, J; Ondrey, F; Samuels, TL; Seabloom, D; Silvaggi, NR; Smith, BC; Vuksanovic, N; Wiedmann, TS; Wuertz, B, 2023) |
" A mouse model of laryngopharyngeal reflux (mechanical laryngeal injury once weekly for 2 weeks and pH 7 solvent/pepsin instillation 3 days/week for 4 weeks) was provided inhibitor by gavage or aerosol (fosamprenavir or darunavir; 5 days/week for 4 weeks; n = 3)." | 4.31 | Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse Model. ( Arnold, LA; Blumin, JH; Bock, J; Goetz, CJ; Johnston, N; MacKinnon, AC; Miller, J; Ondrey, F; Samuels, TL; Seabloom, D; Silvaggi, NR; Smith, BC; Vuksanovic, N; Wiedmann, TS; Wuertz, B, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Johnston, N | 1 |
Samuels, TL | 1 |
Goetz, CJ | 1 |
Arnold, LA | 1 |
Smith, BC | 1 |
Seabloom, D | 1 |
Wuertz, B | 1 |
Ondrey, F | 1 |
Wiedmann, TS | 1 |
Vuksanovic, N | 1 |
Silvaggi, NR | 1 |
MacKinnon, AC | 1 |
Miller, J | 1 |
Bock, J | 1 |
Blumin, JH | 1 |
1 other study available for carbamates and Laryngopharyngeal Reflux
Article | Year |
---|---|
Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse Model.
Topics: Animals; Carbamates; Furans; Laryngopharyngeal Reflux; Larynx; Mice; Pepsin A; Sulfonamides | 2023 |